EUROPEAN ALLIANCE OF ASSOCIATIONS FOR RHEUMATOLO..
EULAR 20263 - 6 June 2026 London
N. Poster
Poster title
Applicant name
Status
 |
|
|
|
| 88-POS | Genetic Determinants and Polygenic Risk Scores for Predicting Psoriatic Arthritis Onset in Patients with Psoriasis | Proton Rahman |  Received |
 |
|||
| 93-POS | Effects of Colony Stimulating-factor 1 Receptor Inhibitors in an In Vitro Cell Culture Model Using Synovial Fluid from Tenosynovial Giant Cell Tumor Patients | Manon Bauerheim | Received |
|
|||
| 117-POS | Somatic NLRP3 Mosaicism Identified After 44 Years of Unexplained Inflammation | Gauravi Khatu | Received |
|
|||
| 182-POS | Closing the gap between narrative and structure: A workflow-integrated clinical documentation improvement tool for enhancing SNOMED CT- coded problem lists in rheumatology practice. | Ilse Hoffman | Received |
|
|||
| 194-POS | Impact of GLP-1 agonists on DMARD "persistence" and clinical outcomes in psoriatic arthritis and axial spondyloarthritis: a global real-world study (TriNetX) | Raquel Almodovar | Received |
|
|||
| 227-POS | Osteoporosis as a common comorbidity in sarcoidosis : results from a transversal prospective study on 101 patients with treated sarcoidosis. | Léna Eberhart | Received |
|
|||
| 238-MPPOS | THE RELATIONSHIP BETWEEN MENISCAL EXTRUSION AND BONE SHAPE (B-SCORE) IN KNEE OSTEOARTHRITIS | Alan Brett | Received |
|
|||
| 275-POS | Changes in Nasopharyngeal Microbiota Composition in Children with Kawasaki Disease: A Case-Control Study | Jordi Antón | Received |
|
|||
| 277-POS | Relationships between host and gut microbiome in Behçet´s syndrome: results of the BEHCETBIOT matched case-control study. | Morgane Joubert | Received |
|
|||
| 307-POS | Achievement and Maintenance of Glucocorticoid Reduction without Increasing Flare Risk in Asian Patients with SLE treated with Anifrolumab: Post-hoc analysis of AZALEA trial | Jiuliang Zhao | Received |
|
|||
| 311-POS | Spanish Multicenter Real-World Registry of Anifrolumab ANIFRO-Reu) in Systemic Lupus Erythematosus: Efficacy and Safety In patients undergoing up to 12 months of follow-up | Tarek Carlos Salman-Monte | Received |
|
|||
| 317-POS | Peripheral blood gene expression as a biomarker of sustained response to B-cell therapy in Sjögren´s disease | Coziana Ciurtin | Received |
|
|||
| 337-POS | Emapalumab Treatment for Patients with Differing Presentations of Macrophage Activation Syndrome (MAS) Secondary to Still´s Disease: Results from a Pooled Analysis of Two Prospective Trials | Kathleen York | Received |
|
|||
| 448-POS | A Multicenter, Double-blind, Randomized, Parallel-arm Study to Compare Efficacy and Safety of BAT2506, a Golimumab Biosimilar, with the Golimumab Reference Product in Patients with Active Psoriatic Arthritis | Hui Wu | Received |
|
|||
| 456-POS | Long-term follow-up of patients in the GOLimumab and Methotrexate versus placebo and methotrexate in early, untreated Psoriatic Arthritis (GOLMePsA) trial | Katya Meridor | Received |
|
|||
| 490-POS | Efficacy of Apremilast in Early Oligoarticular Psoriatic Arthritis by Baseline Active Joint Count: A Post Hoc Analysis of the FOREMOST Study | Jessica Ma | Received |
|
|||
| 540-POS | Efficacy, safety and tolerability of home-based iloprost administration for acral vascular manifestations in Scleroderma patients: a single-centre real life study | Alice Dionisi | Received |
|
|||
| 580-POS | Juvenile systemic sclerosis with dermatomyositis-like overlap features represents a distinct clinical phenotype: updates from the Juvenile Scleroderma Inception Cohort | Ivan Foeldvari | Received |
|
|||
| 601-POS | Clonal hemopoiesis of indeterminate prognosis and relapses in patients with giant cell arteritis. | Oriane Cellier | Received |
|
|||
| 637-POS | Clinical phenotypes and prognosis in Susac syndrome determined by unsupervised hierarchical cluster analysis at diagnosis: a national cohort study | Marie Robert | Received |
|
|||
| 642-POS | Healthy seniors with RMDs and stronger bridge building with Danish municipalities | Henriette Thorseng | Received |
|
|||
| 678-POS | Comparison of Molecular Responses to Autologous and Allogeneic CD19 CAR-T Cell Therapy in Systemic Lupus Erythematosus | Evan Maestri | Received |
|
|||
| 692-POS | Lupus patients with concurrent inflammatory activity and symptom burdens have the lowest medication adherence and experience distinct adherence barriers | Kai Sun | Received |
|
|||
| 701-POS | Memantine Improves Neuropsychological Function in Systemic Lupus Erythematosus: Results from a phase II randomized, double-blind, placebo-controlled trial | Leslie Crofford | Received |
|
|||
| 709-POS | Safety and Efficacy of Allogeneic anti-CD19 STAR-T cell in Severe/Refractory Autoimmune Diseases: A phase I trial | Huji Xu | Received |
|
|||
| 717-POS | Does Timing Matter? Biologic Initiation in SLE | Pablo Martínez Calabuig | Received |
|
|||
| 742-POS | Rare Autoimmune SElf-management (RAISE) programme development: a national survey to determine support needs of people with rare autoimmune rheumatic diseases in the United Kingdom | Sadia Janjua | Received |
|
|||
| 749-POS | Scavenger Receptor MSR1+ Monocytes Trigger Macrophage Activation Syndrome/Haemophagocytic Lymphohistiocytosis by Unleashing Mitochondrial ROS to Activate the NLRP3 inflammasome | Jianfen Meng | Received |
|
|||
| 763-POS | Peripheral Blood UBA1 Variant Allele Frequency Predicts Poor Outcomes in VEXAS Syndrome: A Nationwide Prospective Study | Yohei Kirino | Received |
|
|||
| 776-POS | Prescribing Patterns After First TNF Inhibitor Failure in Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis: A Real-World Cohort Study | Elen Roblin | Received |
|
|||
| 784-POS | Improving early inflammatory arthritis referrals through integrated education and pathway redesign delivered by the Rheumatology Academy and Collaborative Network (RheumACaN) | Antoni Chan | Received |
|
|||
| 786-POS | Prevalence and Clinical Associations of Suboptimal Vitamin D Levels in Patients Referred to a Community Rheumatology Clinic in Canada | Jeewon Kim | Received |
|
|||
| 790-MPPOS | The diagnosis and characteristics of early unidentified arthritis one year after methotrexate therapy | ICHIRO YOSHII | Received |
|
|||
| 798-POS | Real-word persistence of Bimekizumab in Spondyloarthritis and Psoriatic Arthritis: results from the multicentric observational study BIMPACT in Spain | Cristina Valero-Martínez | Received |
|
|||
| 810-POS | Impact of Bimekizumab Use in Spondyloarthritis and Psoriatic Arthritis: safety in Routine Clinical Practice in Spain (BIMPACT) | Cristina Valero-Martínez | Received |
|
|||
| 811-POS | Comparative Real-World Risk of Candidiasis in Ankylosing Spondylitis Treated with Secukinumab Versus Ixekizumab | Mohammed Moutaz Alshaghel | Received |
|
|||
| 813-POS | Time-Stratified Mortality and Safety of JAK Inhibitors vs. Abatacept in RA-ILD:A Target Trial Emulation Using TriNetX (2013-2025) | Po-Cheng Shih | Received |
|
|||
| 839-POS | The Impact of Elevated Serum Urate Levels and Tophi on HRQOL and Daily Functioning in Patients with Uncontrolled Gout | Bhavisha Desai | Received |
|
|||
| 840-POS | Concomitant use of canakinumab may lead to steroid-free dosing of pegloticase | Jeff Peterson | Received |
|
|||
| 856-POS | Inclusion of Older Adults in Pharmacologic Randomized Controlled Clinical Trials of Autoimmune Rheumatic Diseases: A Systematic Review | Jiha Lee | Received |
|
|||
| 870-POS | The clinical potential of serum autotaxin levels at diagnosis as a biomarker for current activity and subsequent complications in patients with microscopic polyangiitis and granulomatosis with polyangiitis | Jihye Chung | Received |
|
|||
| 889-POS | Large-scale multicohort blood transcriptomic analysis identifies a diagnostic rheumatoid arthritis signature associated with disease activity | Andreas Kerschbaumer | Received |
|
|||
| 907-POS | No microorganism triggers the systemic and local lymph node inflammation at disease onset in sarcoidosis patients | Marie Robert | Received |
|
|||
| 908-POS | MONOCYTE EPIGENETIC SIGNATURE IN SARCOIDOSIS | Marie Robert | Received |
|
|||
| 930-POS | Evaluation of the placebo and treatment effect overtime in randomized clinical trials evaluating the efficacy of biologics in axial spondyloarthritis : systematic review and meta-analysis | Léa Perrot | Received |
|
|||
| 966-POS | Synovial tissue heterogeneity in rheumatoid arthritis: from histological pathotypes to spatial transcriptomics | Alice Terrett | Received |
|
|||
| 1008-POS | Clinical heterogeneity and outcomes in patients with antisynthetase antibodies: influence of serological profile, age and sex | Carmen Carrasco Cubero | Received |
|
|||
| 1014-POS | Effectiveness and safety of upadacitinib versus Tacrolimus in anti-MDA5-positive clinically amyopathic dermatomyositis related rapidly interstitial lung disease : a single-centre, retrospective cohort study | Xudong Liu | Received |
|
|||
| 1022-POS | Clinical Spectrum and Long-Term Outcomes of Childhood-Onset Sjögren´s Disease Across Adulthood | Coziana Ciurtin | Received |
|
|||
| 1045-POS | Baseline Pharmacodynamic Markers and Response to Emapalumab in Children and Adults with Macrophage Activation Syndrome (MAS) in Still´s Disease: Results from a Pooled Analysis of Two Prospective Trials | Kathleen York | Received |
|
|||
| 1048-POS | Updated population pharmacokinetic (popPK) model for emapalumab using data from four prospective clinical trials in patients with hemophagocytic lymphohistiocytosis/macrophage activation syndrome (MAS) | Kathleen York | Received |
|
|||
| 1074-POS | Performance of Four Nutritional Screening Tools to Detect Malnutrition According to GLIM Criteria in Systemic Sclerosis: Association with Accumulated Organ Damage | Fernando Ortiz-Márquez | Received |
|
|||
| 1095-POS | Three months of remote monitoring upon discharge vs usual care in patients with subacute or chronic low back pain (AVA-PREPA): a randomised, open-label, phase 3, multicentre, superiority trial | Thomas Davergne | Received |
|
|||
| 1154-POS | The spectrum and relative risk of lung pathology in systemic autoimmune rheumatic diseases: a nationwide postmortem study. | Jessica Fairley | Received |
|
|||
| 1166-POS | Treatment Patterns Before and During Pregnancy in Women with Sjögren´s Disease, Systemic Lupus Erythematosus, or Rheumatoid Arthritis: A Nationwide Population-Based Register Study in Sweden | Kelvin Kwok | Received |
|
|||
| 1211-POS | Maternal and neonatal outcomes following Tofacitinib exposure during pregnancy in inflammatory arthritis: a single-center case series | Bodhisatwa Choudhuri | Received |
|
|||
| 1216-POS | Withdrawal of Alendronate Treatment of Osteoporosis in Rheumatoid Arthritis: Primary findings from the randomised controlled ALOSTRA trial | Anne-Birgitte Garm Blavnsfeldt | Received |
|
|||
| 1275-POS | Early versus late dose reduction of biological treatment in RA patients in stable remission: Results from the randomized NORD-STAR trial | Marte S Heiberg | Received |
|
|||
| 1302-POS | A Vision Transformer-based Transfer Learning Model to Infer Metacarpophalangeal Joint Swelling on Hand Photographs in Patients with Rheumatoid Arthritis | Asier García-Alija | Received |
|
|||
| 1357-POS | Lupus Nexus: A Registry, Biorepository, and Data Exchange Platform to Foster Global Collaborations, Accelerate Reearch and Advance Precision Medicine | Teodora Staeva | Received |
|
|||
| 1375-POS | Longitudinal Outcomes of Juvenile Systemic Lupus Erythematosus and Juvenile Dermatomyositis: Damage and Cardiovascular Risk in Adulthood | Coziana Ciurtin | Received |
|
|||
EULAR 2026
3 - 6 June 2026 London
Search and consult posters online
in an exclusive section
for each poster
in an exclusive section
for each poster
ACTIVE FROM 03/06/2026 TO 03/06/2026
Poster
Gallery
Gallery
Upload
Poster
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
Forum
|
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress.
|
|
||
|
||||
Poster submission deadline 13/05/2026
|
|
